SANOFI ILAC SAN VE TIC

Location: Turkey

Company Type: Factory and Trader

Company Introduction:

SANOFI ILAC SANAYI VE TICARET A.S. is the Turkish subsidiary of Sanofi, a leading global pharmaceutical company. In Turkey, the company operates as both a manufacturing facility (factory) and a trading entity. It is engaged in the production of various pharmaceutical products within its local facilities and also handles the import, marketing, and distribution of a wide range of Sanofi's global portfolio of medicines, vaccines, and consumer healthcare products across Turkey. The company plays a significant role in the Turkish healthcare sector, providing essential medicines and contributing to the local pharmaceutical industry.

Sanofi Ilac San Ve Tic, the Turkish subsidiary of Sanofi, manufactures or sells a wide range of pharmaceutical products and vaccines across various therapeutic areas. These commonly include:

For Diabetes: Insulin products such as Lantus, Toujeo, Apidra, and combination therapies like Soliqua.

For Cardiovascular Diseases: Medications like Plavix (clopidogrel) for preventing blood clots.

For Vaccines: A broad portfolio of vaccines from Sanofi Pasteur, including influenza vaccines (e.g., Vaxigrip Tetra), pediatric vaccines (e.g., Hexaxim), meningococcal vaccines (e.g., Menactra), and tetanus, diphtheria, and pertussis vaccines (e.g., Adacel).

For Immunology and Inflammation: Biologic treatments such as Dupixent for atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, and Aubagio for multiple sclerosis.

For Rare Diseases: Specialized enzyme replacement therapies including Fabrazyme for Fabry disease, Myozyme/Lumizyme for Pompe disease, and Cerezyme for Gaucher disease.

For Oncology: Cancer treatments like Jevtana and Sarclisa.

Sanofi also distributes various general medicines and other prescription products as part of its comprehensive healthcare portfolio in Turkey.